Appendage Management Market: Complications Associated with Improper Device Implantation and Frequent Product Recalls Ham
The prevalence of atrial fibrillation is observed to be constantly increasing and is further expected to grow with greater speed. The risk of heart stroke in individual with atrial fibrillation is multiplied and this creates a threat. The necessity of treatment options for appendage management and to cure atrial fibrillation is thus very high. Traditionally, anticoagulant drugs and blood thinners are used to inhibit blood clot formation in the left atrial appendage, however, with the advancements in medical science and technology, LAA closure devices can be considered potential appendage management alternative to treat atrial fibrillation. Epicardial and Endocardial LAA closure devices are ruled safe and efficient from the clinical trials and approved for sale and implantation.
★
★
★
★
★
46 views • 4 slides
